Ioanna Bountzona
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ioanna Bountzona has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anastasios Kollias
Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
2 shared publications - Angeliki Ntineri
Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
2 shared publications - George S. Stergiou
Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
2 shared publications Andriani Vazeou
First Department of Pediatrics (A.V.), P. & A. Kyriakou Children’s Hospital, Athens, Greece
1 shared publication- Andriani Vazeou
First Department of Pediatrics, P. & A. Kyriakou Children Hospital, Athens, GREECE
1 shared publication - Christina Alamara
Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
1 shared publication
Latest Publications
- 1 June 2021
- Published by Wolters Kluwer Health in Hypertension
- Vol. 77 (6) , 1877-1885
Nighttime Home Blood Pressure in Children: Association with Ambulatory Blood Pressure and Preclinical Organ Damage
This study aimed to investigate a novel technique for nighttime blood pressure evaluation using a home blood pressure (HBP) monitor in children and adolescents, in terms of association with ambulatory blood pressure (ABP) and preclinical organ damage. Children and adolescents (aged 6–18 years) referred for elevated blood pressure were evaluated with ABP (24 hours) and HBP monitoring during daytime (7 days, duplicate morning and evening measurements) and nighttime (automated asleep measurements for 3 nights with 3 hourly measurements/night; Microlife WatchBP Home N). Preclinical organ damage was assessed by echocardiographic left ventricular mass index, carotid intima-media thickness, carotid distensibility coefficient, and carotid-femoral pulse wave velocity. Ninety-one individuals were analyzed (mean age 13.3±2.8 years; 54 men; 17 with elevated ABP). There was a close association between daytime (awake) ABP and HBP (r=0.81/0.77, systolic/diastolic) and between nighttime (asleep) values (r=0.78/0.60) (all P P P P =NS for comparisons between methods). The agreement between nighttime HBP and ABP in identifying individuals with nighttime hypertension (≥95th percentile for nighttime ABP) was 82% (κ=0.49; P P =0.03). In conclusion, in children and adolescents, nighttime HBP monitoring is feasible, is closely associated with nighttime ABP and similarly associated with preclinical organ damage.
- 1 June 2021
- Published by Wolters Kluwer Health in Hypertension
- Vol. 77 (6) , 1877-1885
Nighttime Home Blood Pressure in Children: Association with Ambulatory Blood Pressure and Preclinical Organ Damage
This study aimed to investigate a novel technique for nighttime blood pressure evaluation using a home blood pressure (HBP) monitor in children and adolescents, in terms of association with ambulatory blood pressure (ABP) and preclinical organ damage. Children and adolescents (aged 6–18 years) referred for elevated blood pressure were evaluated with ABP (24 hours) and HBP monitoring during daytime (7 days, duplicate morning and evening measurements) and nighttime (automated asleep measurements for 3 nights with 3 hourly measurements/night; Microlife WatchBP Home N). Preclinical organ damage was assessed by echocardiographic left ventricular mass index, carotid intima-media thickness, carotid distensibility coefficient, and carotid-femoral pulse wave velocity. Ninety-one individuals were analyzed (mean age 13.3±2.8 years; 54 men; 17 with elevated ABP). There was a close association between daytime (awake) ABP and HBP (r=0.81/0.77, systolic/diastolic) and between nighttime (asleep) values (r=0.78/0.60) (all P P P P =NS for comparisons between methods). The agreement between nighttime HBP and ABP in identifying individuals with nighttime hypertension (≥95th percentile for nighttime ABP) was 82% (κ=0.49; P P =0.03). In conclusion, in children and adolescents, nighttime HBP monitoring is feasible, is closely associated with nighttime ABP and similarly associated with preclinical organ damage.
- 3 March 2021
- Published by Wolters Kluwer Health in Hypertension
- Vol. 77 (3) , 993-1000
Reproducibility of Office and Out-of-Office Blood Pressure Measurements in Children
This study aimed to evaluate the reproducibility of office (OBP), ambulatory (ABP), and home blood pressure (HBP) measurements in children and adolescents, and their implications in diagnosing hypertension in clinical practice and in pediatric hypertension research. Apparently healthy children and adolescents referred for suspected hypertension were included. Measurements of 2-visit OBP, 7-day HBP, and 24-hour ABP were performed twice, 1 to 6 months apart. Reproducibility was quantified using the SD of differences between repeated measurements. The sample size of clinical trials comparing the efficacy of antihypertensive drugs using each method was calculated. Fifty-eight individuals were analyzed (mean age, 13.0±2.9 years, 60.3% boys). The reproducibility of 24-hour ABP (SD of differences 5.7/4.5 systolic/diastolic) and HBP (5.9/5.0 mm Hg) were comparable and superior to that of visit-2 OBP (9.2/7.8) and awake (6.7/5.5) or asleep ABP (7.6/6.1). As a consequence, a parallel-group comparative trial aiming to detect a difference in the effect of 2 drugs of 10 mm Hg systolic BP, would require 36 participants when using OBP measurements, 14 using 24-hour ABP, and 15 using HBP (102/34/42 respectively for detecting a 5 mm Hg difference in diastolic BP). For a crossover design trial, the corresponding sample sizes are 9/3/4 for systolic BP and 26/9/11 for diastolic, respectively. These data suggest that in children and adolescents 24-hour ABP and 7-day HBP have similar reproducibility, superior to OBP and daytime or asleep ABP. These findings have major implications in diagnosing hypertension in children in clinical practice and in designing clinical research trials in pediatric hypertension.
- 3 March 2021
- Published by Wolters Kluwer Health in Hypertension
- Vol. 77 (3) , 993-1000
Reproducibility of Office and Out-of-Office Blood Pressure Measurements in Children
This study aimed to evaluate the reproducibility of office (OBP), ambulatory (ABP), and home blood pressure (HBP) measurements in children and adolescents, and their implications in diagnosing hypertension in clinical practice and in pediatric hypertension research. Apparently healthy children and adolescents referred for suspected hypertension were included. Measurements of 2-visit OBP, 7-day HBP, and 24-hour ABP were performed twice, 1 to 6 months apart. Reproducibility was quantified using the SD of differences between repeated measurements. The sample size of clinical trials comparing the efficacy of antihypertensive drugs using each method was calculated. Fifty-eight individuals were analyzed (mean age, 13.0±2.9 years, 60.3% boys). The reproducibility of 24-hour ABP (SD of differences 5.7/4.5 systolic/diastolic) and HBP (5.9/5.0 mm Hg) were comparable and superior to that of visit-2 OBP (9.2/7.8) and awake (6.7/5.5) or asleep ABP (7.6/6.1). As a consequence, a parallel-group comparative trial aiming to detect a difference in the effect of 2 drugs of 10 mm Hg systolic BP, would require 36 participants when using OBP measurements, 14 using 24-hour ABP, and 15 using HBP (102/34/42 respectively for detecting a 5 mm Hg difference in diastolic BP). For a crossover design trial, the corresponding sample sizes are 9/3/4 for systolic BP and 26/9/11 for diastolic, respectively. These data suggest that in children and adolescents 24-hour ABP and 7-day HBP have similar reproducibility, superior to OBP and daytime or asleep ABP. These findings have major implications in diagnosing hypertension in children in clinical practice and in designing clinical research trials in pediatric hypertension.